TP53 and head and neck cancer: In head and neck cancer, under glucose deprivation conditions, p53-P151S, p53-R175H, p53-G245C, and p53-R282W localize to the cytoplasm and inhibit the phosphorylation and activation of AMPK, which is an energy sensor and can repress aerobic glycolysis.